A fed-batch reaction is harder to design than a batch process because of the need to specify all the variables and quantities.

The company seeks to accelerate drug development by automating analysis of study samples.

ADARx Pharmaceuticals CEO Zhen Li found her way to biopharma through Merck, where she was inspired by the application of ...

One of North Carolina's largest biotechnology companies is expanding its operations with a $2 billion investment.

Top experts from Amgen, CBIZ & Intrepid discuss 2025 trends in healthcare, biotech, and life sciences. Explore key insights ...

Scientists have used DNA's self-assembling properties to engineer intricate moiré superlattices at the nanometer ...